KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer. (Q53246286)
Jump to navigation
Jump to search
scientific article published on 6 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer. |
scientific article published on 6 December 2013 |
Statements
KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer. (English)
Maija R J Kohonen-Corish
Jason Tseung
Charles Chan
Nicola Currey
Owen F Dent
Stephen Clarke
Les Bokey
Pierre H Chapuis
6 December 2013
134
12
2820-2828
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference